New Edge Advisors, LLC Ligand Pharmaceuticals Inc Put Options Transaction History
New Edge Advisors, LLC
- $16 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LGND
# of Institutions
275Shares Held
18.5MCall Options Held
30.8KPut Options Held
5.2K-
Black Rock Inc. New York, NY2.87MShares$350 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$254 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.02MShares$124 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3884KShares$108 Million0.11% of portfolio
-
State Street Corp Boston, MA744KShares$90.7 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.06B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...